Artificial intelligence (AI) is transforming the pace of medical breakthroughs. Tackling massive datasets, streamlining workflows, accelerating clinical trials, and optimizing patient care, this technology has become a crucial ally for providers, health systems, and researchers.
Check The Top 25 Healthcare AI Companies of 2025 here.
Waystar has signed a definitive agreement to acquire Iodine Software, a $1.25 billion deal that seeks to empower healthcare payments with more AI capabilities.
Read more here.
Doctors will be able to prescribe a new treatment for people with inflammatory bowel disease (IBD), after the UK medicines watchdog approved guselkumab (Tremfya) for use on the NHS.
Read more here.